| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), the company behind SR CarnoSyn®, a patented, sustained-release version of CarnoSyn® beta-alanine, is showcasing several new...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Barchart, a leading provider of commodity data and agribusiness solutions, has announced the dates and topics for cmdtyExchange 2020 (www.cmdtyexchange.com), its annual event which highlights the...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Portola Pharmaceuticals, Inc.® (NASDAQ: PTLA) today announced that new interim results from the Company's ongoing Phase 2a study of cerdulatinib, an investigational, oral SYK/JAK inhibitor, will...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
New clinical data from Sanofi's oncology and rare blood disorders portfolios and pipelines will be featured, including four oral presentations and 18 posters, at the 61st American Society of...
-
Nov 6, 2019Virtual Press Office and PR Newswire: General Trade show news
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that interim results from a Phase 1 trial studying Actimab-A in combination with CLAG-M have been accepted for...
